Abstracts tagged "computed tomography (CT) and rheumatoid arthritis (RA)"

Abstract Number: 243 • 2017 ACR/ARHP Annual Meeting
Tracer Uptake from High Resolution Bone SPECT/CT Is Linked to Response in Rheumatoid Arthritis Patients
Yasser Abdelhafez^1,2, Felipe Godinez³, Kanika Sood⁴, Rosalie Hagge², Ramsey D Badawi², Robert D Boutin², Siba P. Raychaudhuri⁵ and Abhijit Chaudhari⁶, ¹Nuclear Medicine Unit, South Egypt Cancer Institute, Assiut University, Assiut, Egypt, ²Radiology, Faculty of Medicine, University of California Davis, Sacramento, CA, ³Biomedical Engineering Department, King’s College London, London, United Kingdom, ⁴Rheumatology Section, Sacramento Veterans Affairs Medical Center, Sacramento, CA, ⁵Rheumatology, VA Sacramento Medical CenterUC Davis School of Medicine, Mather, CA, ⁶Radiology, UC Davis School of Medicine, Sacramento, CA
Tracer Uptake from High Resolution Bone SPECT/CT is Linked to Response in Rheumatoid Arthritis Patients.Background/Purpose: To evaluate the association between response to TNF-_ blockers and…
Abstract Number: 1964 • 2013 ACR/ARHP Annual Meeting
Quantitative Erosion Volume Measurement From Computed Tomography
Jeffrey W. Duryea¹, Daniel H. Solomon², Bing LU³, Ruby Russell¹, Roger Han⁴, Ellen M. Gravallese⁵ and Jonathan Kay⁶, ¹Radiology, Brigham and Women's Hospital, Boston, MA, ²Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, ³Rheumatology/Immunology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, ⁴Medicone, Brigham and Women's Hospital, Boston, MA, ⁵Department of Medicine, Division of Rheumatology, UMass Memorial Medical Center, Worcester, MA, ⁶UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA
Novel Methodology to Quantify Erosion Volume in Rheumatoid Arthritis using Computed TomographyBackground/Purpose: Rheumatoid arthritis (RA) causes two key structural changes that are visible on plain…
Abstract Number: 2581 • 2012 ACR/ARHP Annual Meeting
Anti- Citrullinated Protein Antibodies but Not Rheumatoid Factor Are Associated with Larger Bone Erosions in rheumatoid arthritis patients- a Cross-Sectional Micro Computed Tomography Study
Carolin Hecht¹, Stephanie Finzel¹, Matthias Englbrecht¹, Sarah Schmidt¹, Juergen Rech², Elizabeth Araujo¹ and Georg Schett¹, ¹Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: Anti- citrullinated protein antibodies (ACPA) are known to be associated with joint destruction and a more severe disease course in rheumatoid arthritis (RA) patients.…
Abstract Number: 1010 • 2012 ACR/ARHP Annual Meeting
Bone Loss Before Clinical Onset of Rheumatoid Arthritis o Subjects with Anti-Citrullinated Protein Antibodies
Stephanie Finzel¹, Veronika Lang², Arnd Kleyer¹, Juergen Rech³, Bernhard Manger¹, Elizabeth Araujo¹, Axel J. Hueber⁴, Ulrike Harre⁵ and Georg Schett¹, ¹Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Dept. of Medicine, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Germany, ³Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, ⁴Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ⁵Institute for Clinical Immunology, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are a major risk factor for rapid disease progression in rheumatoid arthritis (RA). We have recently shown that ACPA directly…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].